ArticleNaunyn-Schmiedeberg's archives of pharmacology2025
Association of stroke and mortality among patients receiving heart transplantation-a nationwide study.
Article in Naunyn-Schmiedeberg's archives of pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aims to define the association of heart transplantation with incident stroke, cardiovascular (CV) and all-cause death. The incidence rate (IR) was calculated by dividing the number of outcomes by the summed person-years in the group during the follow-up period. Crude and adjusted hazard ratios (HRs) and the corresponding 95% confidence intervals (CIs) were estimated through univariable and multivariable Cox proportional hazards models. Propensity score (PS) matching analysis was adopted to minimize the differences between the two cohorts. Each cohort had 13,948 study participants. Compared to the control group, patients with heart transplantation had a higher risk of stroke (adjusted HR [95% CI] = 2.96 [2.72, 3.22]) and CV death (adjusted HR [95% CI] = 5.33 [4.87, 5.83]), and the risk is higher in the subgroup of the male sex, without comorbidity, and follow-up period < 10 years. Among patients who underwent cardiac transplantation, the subgroups of the male sex, without comorbidities and short follow-up period are at higher risk for incident stroke and CV death.
Indexed as
Identifiers
40105920What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.